Kathy Haaland
Kathy Haaland is a board certified clinical neuropsychologist, a Research Career Scientist at the New
Mexico VA Healthcare System and Professor of Psychiatry and Neurology at the University of New
Mexico School of Medicine in Albuquerque, NM, USA. She is a lifelong clinician, researcher, and
teacher. She is past-president of Division 40 (Clinical Neuropsychology) of the American Psychological
Association and of the American Board of Clinical Neuropsychology. She is a fellow of the American
Psychological Association, and in 2012, she received the Distinguished Lifetime Career Contribution
Award from the National Academy of Neuropsychology. In addition to her clinical work, Kathy has been
continuously funded for her clinical research since 1981, and she has published over 100 papers and
chapters largely focused on the cognitive and neuroanatomical correlates of complex movement,
especially after unilateral stroke with a particular focus on limb apraxia. She has been continuously
involved in INS for many years beginning as program chair in 1983, as a board member in the 1980s, as
Symposium Editor (1999-2005) of the Journal of the International Neuropsychological Society (JINS), and
as Editor-in-Chief of JINS for the past 9 years (2005-2013). All of these positions have made her aware
of the enormous breadth, creativity and clinical and scientific rigor in the INS membership. As a lifelong
clinician, teacher, and researcher, Kathy particularly values how INS brings clinical practice, training, and
science together, and she is enthusiastic about further integrating international and multidisciplinary
perspectives to enhance INS’s impact. Finally, she wants to encourage greater involvement of early- and
mid-career professionals, including students, in INS leadership, as a way of stimulating new visions for
INS and ensuring continued active participation of new generations of neuropsychologists in the
organization.
Katie Mateer
Dr. Catherine Mateer, MSc, PhD., RPsych, ABCN/CN is a Professor in the Department of Psychology,
University of Victoria, British Columbia, Canada. She has served there as Director of Clinical Training for
the Graduate Program in Clinical Psychology, and oversaw development of the Clinical Neuropsychology
program. She has also served as Chair of Psychology, and is currently the Associate Vice President
Academic Planning in the Office of the Provost. Mateer received an MSc in Communication Disorders
from the University of Wisconsin, a PhD in Psychology from the University of Western Ontario, and
postdoctoral training in the Department of Neurological Surgery, University of Washington. In the 1980’s,
as Clinical Director of the Good Samaritan Hospital Neuropsychology Service, Mateer began pioneering
work in the area of cognitive rehabilitation. She is well known internationally for her work in the
management of disorders of attention, memory, executive function and self-regulation following acquired
brain injury. She has authored three books on neuropsychological intervention and over 100 peer
reviewed articles and book chapters on a wide range of topics in clinical neuropsychology. She is a
Fellow of the American and the Canadian Psychological Associations, and is board certified in Clinical
Neuropsychology by the American Board of Clinical Neuropsychology. She served on the Board of the
INS (1991-93), and as Secretary to the INS Board (2006-09). Awards include the APA Roger Barker
Distinguished Research Contribution Award in Rehabilitation Psychology, the Mitchell Rosenthal Award
from the American Congress of Rehabilitation Medicine, and an award from the British Columbia
Psychology Association named for her, the Catherine Mateer Scientist-Practitioner Award.
Paul Cirino
Paul T. Cirino is an Associate Professor in the Department of Psychology at the University of Houston,
where he advises graduate students in the Neuropsychology Track of the Clinical Psychology program.
He is also on faculty of the Texas Institute for Measurement, Evaluation, and Statistics (TIMES). Dr.
Cirino received his Ph.D. in Clinical Neuropsychology from the University of Houston, completed an APA
Internship at the University of Arizona Health Sciences Center, and was a Postdoctoral Fellow in
Developmental Neuropsychology at Georgia State University. Dr. Cirino has also held positions at the
Kennedy Krieger Institute and at Georgia State University.
Dr. Cirino has been an active member of INS for nearly 20 years. He served as Chair of the Program
Committee for the 37thAnnual Meeting (Atlanta), and also served as a program committee member in
2010 and 2011. Dr. Cirino is also highly active in the local Houston Neuropsychological Society (HNS),
and has maintained a leadership role there since 2004, including most recently as Treasurer. He is also
Treasurer of the Association for Doctoral Education in Clinical Neuropsychology (ADECN).
Dr. Cirino’s primary interest is neuropsychology in a developmental context, including math and reading
learning disabilities, spina bifida, and other neurodevelopmental disorders. He has ongoing interests in
executive functions and working memory, as well as measurement and methodology. Dr. Cirino has a
history of grant funding, including as principal investigator, from both the Institute of Education Sciences
(IES) and the National Institutes of Health (NIH). He has also served on grant review panels for both IES
and NIH. Dr. Cirino serves on four editorial boards, and is an active reviewer for many other journals in
the areas of neuropsychology, educational psychology, learning disabilities, and assessment. He is
author or co-author of 70 peer-reviewed journal articles, in addition to many more presentations and other
scholarly works.
Bruce Hermann
Bruce Hermann is Professor in the Department of Neurology at the University of Wisconsin School of
Medicine and Public Health and Director of the Charles Matthews Neuropsychology Lab. After obtaining
his PhD in 1977 he worked at the University of Illinois Medical Center in Chicago (1978-1985), University
of Tennessee-Memphis and Semmes-Murphey Clinic (1985-1995), and the University of Wisconsin
(1995- ). He is ABPP-CN and a fellow of APA Division 40 and NAN. His broad research interests include
the cognitive and behavioral complications of the epilepsies and the outcomes of epilepsy surgery. Of
particular interest have been the neuropsychological outcomes of anterior temporal lobectomy and the
alterations in surgical techniques and approach that may minimize morbidity to memory and language,
the impact of chronic epilepsy on the course of cognitive and brain aging, and most recently the effects of
childhood onset epilepsies on cognitive and brain development. For the past 10 years he has also had
the opportunity to work with the UW research group dedicated to the detection of preclinical Alzheimer’s
disease—the Wisconsin Registry for Alzheimer’s Prevention (WRAP). He has served on the boards of the
American Epilepsy Society (AES) and the Epilepsy Foundation (EF) where he chaired the Research
Committee, later elected to the Chair of the EF Professional Advisory Board. He took a lead role in
behavioral science activities within both organizations including the AES Neurobehavioral Fellows
Program, designed to attract and retain young neuropsychologists and other behavioral scientists in the
field of epilepsy.
Peter Arnett
Peter Arnett received his Ph.D. in Psychology (Clinical) from the University of Wisconsin – Madison, and
completed a post-doctoral fellowship in Clinical Neuropsychology at the Medical College of Wisconsin. He
is currently a Psychology Professor and Director of Clinical Training at Penn State University where he
teaches undergraduate and graduate courses in neuropsychology, and does clinical supervision of
doctoral students conducting neuropsychological evaluations on a range of neurological patients. Dr.
Arnett’s research has focused on the study of secondary influences on cognitive functioning in persons
with multiple sclerosis (MS) and mild traumatic brain injury. Related to this research emphasis, Dr. Arnett
edited a book published this year by Oxford University Press entitled, Secondary Influences on
Neuropsychological Test Performance. Recent empirical work has involved the study of neural networks
underlying depression in MS, funded by the National Multiple Sclerosis Society. He and his students
have also recently examined baseline variables predicting outcome in sports-related concussion,
including factors such as cognitive reserve, neurocognitive variability, and demographic characteristics.
Dr. Arnett was program Co-Chair for the 2010 INS Mid-Year Meeting in Krakow, and also a member of a
past INS program committee. Dr. Arnett is the director of the Neuropsychology of Sports-Related
Concussion and Multiple Sclerosis programs at Penn State University, a fellow of the National Academy
of Neuropsychology (NAN), and past winner of NAN’s Nelson Butters Award for Research Contributions
to Clinical Neuropsychology. He is the author of over 90 research articles and book chapters, as well as
over 170 conference presentations and an editorial board member of several journals including the
Journal of the International Neuropsychological Society, Neuropsychology, and Archives of Clinical
Neuropsychology. Dr. Arnett has given invited talks to numerous organizations including the New York
Academy of Sciences, the Argentine Congress on Neuropsychiatry and Cognitive Neuroscience, and the
Spanish Foundation for Multiple Sclerosis, among others. Dr. Arnett has devoted much of his career to
training students, and has been the primary advisor to 17 completed doctoral dissertations, 18 master’s
theses, and numerous undergraduate honor’s theses. He has been a member of INS since 1992.
John Gunstad
John Gunstad is Associate Professor in the Department of Psychology at Kent State University. He
obtained a B.A. in psychology from Moorhead State University and both his M.S. and Ph.D. in clinical
psychology with concentration in clinical neuropsychology from Ohio University. He completed internship
and F32 postdoctoral fellowship at Brown Medical School, where he began a line of research in the
neurocognitive effects of medical conditions including obesity and cardiovascular disease. He has more
than 150 publications and series of NIH grants, including projects examining the cognitive benefits of
bariatric surgery and role of exercise in protecting the brain in heart failure. These findings have been
applied to other populations within his lab, including examining the contribution of cognitive dysfunction to
poor health habits, recovery from traumatic brain injury, and mechanisms by which extreme
environmental conditions impair cognitive function. Dr. Gunstad has also been active in the field, including
grant reviews for NIH and the Alzheimer’s Association, assisting as an INS program committee member,
and serving as a member of the APA Division 40/Society for Clinical Neuropsychology Scientific Advisory
committee. Dr. Gunstad received the Early Career Research Award from the International
Neuropsychological Society in 2011 and awards for teaching, student mentorship, and research from
Kent State University.
Scott Langenecker
Scott Langenecker is an Associate Professor at the University of Illinois at Chicago. He directs the
Cognitive Neuroscience Center and his own laboratory, Multifaceted Explorations of the Neurobiology of
Depressive Disorders (MEND2). Dr. Langenecker completed a B.S. in Psychology and in History from the
University of Wisconsin in 1993. He completed his graduate studies at Marquette University from 19962001. His internship was at Long Island Jewish Medical Center, his postdoctoral fellowship in Clinical
Neuropsychology at the University of Michigan (UM) from 2001-2003. He was an Assistant Professor at
UM from 2003-2012. Dr. Langenecker has received a K-23 Career Development Award, a Biobehavioral
Research Award for Innovative News Scientists RO1, and second RO1 from the NIMH to investigate
mechanisms, subtypes and predictors of treatment response in mood disorders. He has served in
scientific committees for INS meetings, served on the practice test development committee for Being
Ready for Accreditation in Neuropsychology (BRAIN) group. He is in the process of completing his
accreditation in Clinical Neuropsychology. He has published over 50 peer reviewed papers, over 200
abstracts, 3 chapters, and 2 book reviews, given over 50 presentations, and reviews for over 20
journals. He serves as a standing member of the Center for Scientific Review at NIMH. He is active in
mentorship of practicum students and postdoctoral fellows, including clinical and research mentorship of
over twenty trainees in his career. Dr. Langenecker also works in translational neuropsychology,
developing neuroimaging tasks, transforming them for clinical applications, and publishing normative
papers for these tests.
Emilia Lojek
Emilia Lojek, PhD, a Full Professor at the Faculty of Psychology, University of Warsaw, Poland, is a
neuropsychologist who joined the INS in 1994. She complited MA, PhD and further scientific degrees in
psychology and neuropsychology at the UW. As a Fellow of the British Council, the Ginsberg’s, the EU
TEMPUS and the Kosciuszko Foundations she also extended her studies in neuropsychology at
University of Cambridge, University College London and Ohio State University. She serves as Director of
Warsaw International Studies in Psychology at UW and has a record of leadership in the Commissions of
the Polish Neuropsychological Society and the Polish Academy of Sciences. She was the INS regional
representative for Eastern European countries, coordinating the INS support for these countries,
contributing to the INS Net. She was appointed chair of the local organizing committee of the INS meeting
in Krakow 2010. She has published 4 books, over 70 research articles and chapters on a wild range of
topics ranging from communication disorders in brain damaged patients, neuropsychological changes in
neurodegenerative and psychiatric diseases to the stability of neuro-cognitive patterns in HIV infection.
She has been involved in the Neuropsychology Research Program: HIV Drug and Alcohol Studies at the
OSU. Currently she leads the international research program on the effect of aging on cognitive and
chemosensory functions in HIV infected individuals. As an author or co-author she has adapted and
standardized in Polish Neuropsychological tests (H-RNTB, RHLB, RFFT, CVLT, CTT). She has received
national awards for her scientific achievements.
Dorene Rentz
Dorene M. Rentz, PsyD, is an Associate Professor of Neurology at Harvard Medical School with dual
appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts
General Hospital, Boston, Massachusetts. She completed her degree in clinical psychology in 1986 and
has worked as a clinical neuropsychologist for 27 years. She has supervised numerous students and
post-doctoral fellows and is an author of over 60 peer-reviewed manuscripts and book chapters. Her
dissertation on the Rapidity of Disease Progression in Alzheimer’s disease was the start of her long
career in understanding the earliest changes associated with Alzheimer’s disease. She a recipient, as
well as a co-investigator on numerous research grants and has worked closely for 15 years with Drs.
Reisa Sperling and Keith Johnson exploring the earliest cognitive changes associated with Alzheimer’s
disease using fMRI and PET imaging. More recently, she has been developing sensitive memory tests for
detecting biomarker evidence of preclinical Alzheimer’s disease. At present, she serves as the CoDirector of the Center for Alzheimer Research and Treatment and the Director of Neuropsychology at the
Massachusetts Alzheimer’s Disease Research Center. She is intimately involved in designing the
cognitive outcome measures for a new secondary prevention trial aimed at treating asymptomatic
individuals at risk for Alzheimer’s disease. On a local level, she has provided leadership to the
Massachusetts Neuropsychological Society, serving as an elected member of the Board of Directors and
then as President. In this capacity, she assisted the Society to define Neuropsychology as a medical
discipline and worked with state and local leaders to establish Neuropsychological Testing as a
reimbursable service under Medicare and Medicaid in the Commonwealth of Massachusetts. More
recently, her leadership skills were called upon to serve as the Program Committee Chair for the 2013
Annual Meeting of the International Neuropsychological Society in Waikoloa, Hawaii. She has been a
member of INS since 1987, has served on the Scientific Review Committee and would be delighted to
serve on the INS Board of Directors, if elected.
Guy Vingerhoets
Guy Vingerhoets is a Full Professor of Neuropsychology at the Faculty of Psychology and Educational
Sciences at Ghent University, Belgium. He completed his studies in Clinical Psychology in 1985 and
obtained his PhD in 1995 on the cognitive consequences of open-heart surgery. He was then offered a
post-doc position at the Faculty of Medicine and Health Sciences at Ghent University where he became
an Associate Professor in 2001. During this period he performed research in clinical neuropsychology
(Parkinson’s disease, epilepsy, Alzheimer’s disease, stroke, and multiple sclerosis) and medical
neuropsychology (cardiopulmonary bypass, congenital heart disease, carotid artery disease). Besides
behavioral methods, his research also includes the use of neuroimaging (fMRI, PET, fTCD). Over the last
seven years he developed a specific interest in motor cognition and investigated the neural network of
praxis, object affordances, and handedness, as well as the clinical manifestations of disturbed motor
control in patients with apraxia and developmental coordination disorder. He was appointed Full
Professor at the Faculty of Psychology and Educational Sciences in 2012. He is author of more than 100
journal articles and book chapters covering a wide range of topics in clinical and cognitive
neuropsychology. He is a founding member of the Ghent Institute for Functional and Metabolic Imaging
and received numerous research grants for clinical and fundamental brain research.
Guy Vingerhoets teaches several courses in neuropsychology at the Faculties of Medicine and Health
Sciences and Psychology and Educational Sciences to graduate and undergraduate students. He
supervised numerous Master theses and was promoter of five Doctoral theses. Together with his
colleagues from the Free University of Brussels and KU Leuven he initiated the first academic
postgraduate training of neuropsychology in Flanders, Belgium.
Guy Vingerhoets has been a member of INS since 1987. In addition, he increasingly became involved in
organizations that aim to promote neuropsychology on a national and European level. He joined the
board of the Dutch Neuropsychological Society in 2000 and became President of this society in the period
2007-2011. He was the representative of the Dutch society when the Federation of the European
Societies for Neuropsychology (FESN) was founded in 2008 and he later became the President of FESN
from 2010 until 2013. During his term European conferences were organized in Amsterdam, Basel, and
Berlin, and three more countries joined the Federation. He represents FESN in the European Brain
Council (EBC) and the European Federation of Psychological Associations (EFPA).